Nicola Zambrano, PhD in Biotechnology, is Full Professor of Molecular Biology at the Department of Molecular Medicine and Medical Biotechnology of the University of Naples Federico II. He is Principal Investigator at CEINGE-Biotecnologie Avanzate Franco Salvatore, established in Naples, Italy, where he currently explores mechanisms of hypoxic responses and cancer immunotherapy/oncovirotherapy in immunocompetent murine preclinical models.